Comparing two surgeries for esophageal cancer after pre-treatment
Part of Cancer, Digestive system clinical trials.
This trial compares two different surgical approaches for people with esophageal cancer who have already received treatment like chemo or radiation before surgery. It aims to see which method works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have squamous cell carcinoma (the most common type) of the esophagus, and the tumor is in the chest area.
- You have received chemotherapy, radiation, or immunotherapy before surgery.
- You have not had any previous chest surgery or another type of cancer.
- You are able to consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares robot-assisted surgery with the standard open chest operation to remove esophagus and nearby tissue. It may help you understand which approach works better and is safer for patients whose cancer can be surgically removed.
This trial compares a robot-assisted approach to a standard minimally invasive approach for surgery in people with certain types of esophageal or gastroesophageal junction cancer that can be removed. It aims to see which surgery method works better and is safer for these patients.
This trial compares robotic and laparoscopic surgery for stomach cancer patients who have already received chemotherapy or targeted therapy. It aims to see which approach leads to better outcomes after neoadjuvant (pre-surgery) treatment.
This trial compares two types of minimally invasive surgery for esophageal cancer to see which is better. It is for people whose cancer can be removed with surgery and who are healthy enough for either approach.
This trial compares different surgical methods (robotic, VATS, or open surgery) used to remove lung cancer after patients have had chemotherapy and/or immunotherapy before their operation. It looks at results from five specialized hospitals to help understand which approach may work best.
This trial compares two approaches for people with esophageal cancer that has shrunk or disappeared after initial chemotherapy combined with immunotherapy. It looks at whether adding targeted radiation (DCRT) or surgery is better. The goal is to find the most effective next step for eligible patients.
Hear when a new Surgical Procedure, Unspecified trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.